Motley Fool: Why AbbVie Stock Is Sinking and Allergan Is Soaring Today

What happened Shares of AbbVie (NYSE:ABBV) were sinking by 14.8% as of 10:38 a.m. EDT on Tuesday while shares of Allergan (NYSE:AGN) were soaring by 26.7%. These big moves came after AbbVie announced plans to acquire Allergan for $63 billion.…

Advertisements

Motley Fool: 5 Top Pharmaceutical Stocks to Buy in 2019

More than $320 billion was spent on prescription drugs in the U.S. in 2016, a figure that’s expected to nearly double to $610 billion by 2021, according to IQVIA (formerly QuintilesIMS). With so much money being spent on necessary medicines,…

Motley Fool: 4 Blockbuster Drug Launches to Watch in 2019

Get ready for some blockbuster drug launches that could get intense.  Clarivate Analytics has offered a report on experimental drugs entering the market soon that are expected to generate sales above $1 billion in 2023. Every potential blockbuster is important to…

Motley Fool: 3 Top Biotech Stocks to Buy in October

If Regeneron Pharmaceuticals (NASDAQ:REGN), Incyte Corporation (NASDAQ:INCY), and AbbVie Inc. (NYSE:ABBV) aren’t on your list of stocks to consider buying this month, you might want to add them. These three Motley Fool contributors think new approvals could help drive Regeneron Pharmaceuticals and…